Shunji Tanefusa
Keine laufenden Positionen mehr
Karriereverlauf von Shunji Tanefusa
Ehemalige bekannte Positionen von Shunji Tanefusa
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JAPAN PURE CHEMICAL CO.,LTD. | Direktor/Vorstandsmitglied | 01.08.1999 | 21.06.2019 |
| Independent Dir/Board Member | 01.08.1999 | 21.06.2019 | |
| ALCONIX CORPORATION | Direktor/Vorstandsmitglied | 04.03.2011 | 20.06.2019 |
| Independent Dir/Board Member | 01.03.2001 | 20.06.2019 | |
Academia Co. Ltd.
 Academia Co. Ltd. Investment ManagersFinance Academia Co. Ltd. is an independent private equity investment firm located in Tokyo, Japan. They are the investment managers of Minerva No 1 Investment LP, which owns ZK Holdings KK, their acquisition vehicle. | Chief Investment Officer | 01.09.2006 | 01.03.2012 |
| Präsident | 01.09.2006 | 01.03.2012 | |
Minerva Intelligence Co., Ltd.
 Minerva Intelligence Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Minerva Intelligence Co., Ltd. operates as a holding company with interests in cram schools operational business. It owns and operates a network of English conversation schools for children. It also provides the planning, production and sale of learning materials. The company was founded in May 1975 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | - | - |
| SEED CO.,LTD. | Comptroller/Controller/Auditor | - | - |
| Fujigin Capital Co., Ltd. | Direktor/Vorstandsmitglied | 01.06.1991 | - |
| Präsident | 01.06.1991 | - | |
M's Science Corp.
 M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Comptroller/Controller/Auditor | 08.03.2011 | - |
| ARTNATURE INC. | Direktor/Vorstandsmitglied | 04.03.2011 | - |
| Fuji Bank Ltd. | Direktor/Vorstandsmitglied | 01.04.1960 | - |
| Corporate Officer/Principal | 01.04.1960 | - |
Ausbildung von Shunji Tanefusa
| Keio University | Undergraduate Degree |
Statistik
International
| Japan | 11 |
Operativ
| Director/Board Member | 6 |
| President | 2 |
| Independent Dir/Board Member | 2 |
Sektoral
| Finance | 3 |
| Commercial Services | 3 |
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| JAPAN PURE CHEMICAL CO.,LTD. | Process Industries |
| ALCONIX CORPORATION | Producer Manufacturing |
| SEED CO.,LTD. | Health Technology |
| ARTNATURE INC. | Consumer Non-Durables |
| Private Unternehmen | 5 |
|---|---|
| Fuji Bank Ltd. | Finance |
Minerva Intelligence Co., Ltd.
Minerva Intelligence Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Minerva Intelligence Co., Ltd. operates as a holding company with interests in cram schools operational business. It owns and operates a network of English conversation schools for children. It also provides the planning, production and sale of learning materials. The company was founded in May 1975 and is headquartered in Tokyo, Japan. | Commercial Services |
Academia Co. Ltd.
Academia Co. Ltd. Investment ManagersFinance Academia Co. Ltd. is an independent private equity investment firm located in Tokyo, Japan. They are the investment managers of Minerva No 1 Investment LP, which owns ZK Holdings KK, their acquisition vehicle. | Finance |
M's Science Corp.
M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |
| Fujigin Capital Co., Ltd. |
- Börse
- Insiders
- Shunji Tanefusa
- Erfahrung
